Daniel Drucker recognized with 2025 Warren Triennial Prize

Daniel Drucker, a senior investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health and a University Professor of medicine in the University of Toronto's Temerty Faculty of Medicine, is one of four researchers to be honoured with the prestigious 2025 Warren Triennial Prize. 

Awarded by Massachusetts General Hospital, the triennial prize recognizes scientists whose work is expected to have a major impact on the future of medicine.

Drucker was recognized for uncovering the role of glucagon-like peptide-1 (GLP-1), a gut hormone that has enabled the development of novel therapeutics to treat type 2 diabetes and obesity and introduced new avenues of exploration for treatment of neurodegenerative diseases. He shared the prize with Professors Joel Habener of Harvard Medical School, Svetlana Mojsov of Rockefeller University and Jens Juul Holst of the University of Copenhagen.

“Professor Drucker’s groundbreaking work on GLP-1 holds the promise of transforming the lives of millions of patients around the world,” said Leah Cowen, U of T’s vice-president, research and innovation, and strategic initiatives. “The Warren Triennial Prize is a worthy recognition of his impactful scholarship, and we are proud to count him among our distinguished faculty at the University of Toronto.”